India  
NewsR.in
> >

Concert Pharmaceuticals Announces CTP-543 Phase 2 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2019 EADV Congress

Business Wire Thursday, 12 September 2019 ()
Concert Pharmaceuticals Announces CTP-543 Phase 2 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2019 EADV CongressLEXINGTON, Mass.--(BUSINESS WIRE)--$CNCE #CNCE--Concert will present CTP-543 Phase 2 results in alopecia areata during the late breaking news session at the EADV Annual Congress in October 2019.
0
shares
ShareTweetSavePostSend
 

You Might Like

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2019 newsR Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest